AKTX

Akari Therapeutics
AKTX

Overview Fund Trends Analyst Outlook Journalist POV

14 hedge funds and large institutions have $1.99M invested in Akari Therapeutics in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
14
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$25K
2
+$2K

Top Sellers

1
-$141K
2
-$23.8K
3
-$9.9K
4
HF
HRT Financial
New York
-$3.55K
5
Morgan Stanley
Morgan Stanley
New York
-$1.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$761K
2
$737K
3
$146K
4
$107K
5
$62K
6
$49K
7
$33K
8
$31K
9
$25K
10
$20K
11
$9K
12
$5K
13
$3K
14
$2K